314 related articles for article (PubMed ID: 6150781)
1. Buspirone, a novel nonbenzodiazepine anxiolytic.
Kastenholz KV; Crismon ML
Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
[TBL] [Abstract][Full Text] [Related]
2. Notes on buspirone's mechanisms of action.
Garattini S; Caccia S; Mennini T
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
[TBL] [Abstract][Full Text] [Related]
3. Buspirone: chemistry, pharmacology, and behavior.
Skolnick P; Paul SM
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072
[TBL] [Abstract][Full Text] [Related]
4. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.
Goldberg HL
Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170
[TBL] [Abstract][Full Text] [Related]
5. Nonbenzodiazepine anxiolytics: clinical usefulness.
Rickels K
J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
[TBL] [Abstract][Full Text] [Related]
6. Buspirone: a new type of anxiolytic.
Dommisse CS; DeVane CL
Drug Intell Clin Pharm; 1985 Sep; 19(9):624-8. PubMed ID: 2864225
[TBL] [Abstract][Full Text] [Related]
7. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.
Goa KL; Ward A
Drugs; 1986 Aug; 32(2):114-29. PubMed ID: 2874976
[TBL] [Abstract][Full Text] [Related]
8. The side effect profile of buspirone in comparison to active controls and placebo.
Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
[TBL] [Abstract][Full Text] [Related]
9. Buspirone: chemical profile of a new class of anxioselective agents.
Temple DL; Yevich JP; New JS
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
[TBL] [Abstract][Full Text] [Related]
10. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
Uhlenhuth EH
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and clinical effects of buspirone.
Taylor DP; Eison MS; Riblet LA; Vandermaelen CP
Pharmacol Biochem Behav; 1985 Oct; 23(4):687-94. PubMed ID: 2866549
[TBL] [Abstract][Full Text] [Related]
12. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and neurochemistry of buspirone.
Riblet LA; Taylor DP; Eison MS; Stanton HC
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):11-8. PubMed ID: 6130068
[TBL] [Abstract][Full Text] [Related]
14. Buspirone: an update on a unique anxiolytic agent.
Jann MW
Pharmacotherapy; 1988; 8(2):100-16. PubMed ID: 3041384
[TBL] [Abstract][Full Text] [Related]
15. [New anxiolytic drugs: methodological issues].
Ginestet D; Corruble E
Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions in controlled clinical trials.
Gershon S
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):95-9. PubMed ID: 6130080
[TBL] [Abstract][Full Text] [Related]
17. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states.
Olajide D; Lader M
J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344
[TBL] [Abstract][Full Text] [Related]
18. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
Lader M; Olajide D
J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
[TBL] [Abstract][Full Text] [Related]
19. Buspirone: multicenter efficacy study.
Wheatley D
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
[TBL] [Abstract][Full Text] [Related]
20. Buspirone's advantages over benzodiazepine anxiolytics.
Ereshefsky L
Clin Pharm; 1984; 3(6):654-5. PubMed ID: 6150783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
